-
1
-
-
0027483308
-
Characterization and epitope mapping of a new panel of monoclonal antibodies to estradiol receptor
-
Abbondanza C, de Falco A, Nigro V, Medici N, Armetta I, Molinari AM, Moncharmont B, Puca GA. 1993. Characterization and epitope mapping of a new panel of monoclonal antibodies to estradiol receptor. Steroids 58: 4-12.
-
(1993)
Steroids
, vol.58
, pp. 4-12
-
-
Abbondanza, C.1
de Falco, A.2
Nigro, V.3
Medici, N.4
Armetta, I.5
Molinari, A.M.6
Moncharmont, B.7
Puca, G.A.8
-
2
-
-
12944328744
-
The retinoblastoma interacting zinc-finger protein RIZ is a downstream effector of estrogen action
-
Abbondanza C, Medici N, Nigro V, Rossi V, Gallo L, Piluso G, Belsito A, Roscigno A, Bontempo P, Puca AA, Molinari AM, Moncharmont B, Puca GA. 2000. The retinoblastoma interacting zinc-finger protein RIZ is a downstream effector of estrogen action. Proc Natl Acad Sci USA 97: 3130-3135.
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 3130-3135
-
-
Abbondanza, C.1
Medici, N.2
Nigro, V.3
Rossi, V.4
Gallo, L.5
Piluso, G.6
Belsito, A.7
Roscigno, A.8
Bontempo, P.9
Puca, A.A.10
Molinari, A.M.11
Moncharmont, B.12
Puca, G.A.13
-
3
-
-
4944246588
-
Loss of ERbeta expression as a common step in estrogen-dependent tumor progression
-
Bardin A, Boulle N, Lazennec G, Vignon F, Pujol P. 2004. Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer 11: 537-551.
-
(2004)
Endocr Relat Cancer
, vol.11
, pp. 537-551
-
-
Bardin, A.1
Boulle, N.2
Lazennec, G.3
Vignon, F.4
Pujol, P.5
-
4
-
-
35648959800
-
Estrogen and prostate cancer: An eclipsed truth in an androgen-dominated scenario
-
Carruba G. 2007. Estrogen and prostate cancer: An eclipsed truth in an androgen-dominated scenario. J Cell Biochem 102: 899-911.
-
(2007)
J Cell Biochem
, vol.102
, pp. 899-911
-
-
Carruba, G.1
-
5
-
-
0032973606
-
Estrogen receptor-beta: Implications for the prostate gland
-
Chang WY, Prins GS. 1999. Estrogen receptor-beta: Implications for the prostate gland. Prostate 40: 115-124.
-
(1999)
Prostate
, vol.40
, pp. 115-124
-
-
Chang, W.Y.1
Prins, G.S.2
-
6
-
-
0038504065
-
PAR-4 transcriptionally regulates Bcl-2 through a WT1-binding site on the bcl-2 promoter
-
Cheema SK, Mishra SK, Rangnekar VM, Tari AM, Kumar R, Lopez-Berestein G. 2003. PAR-4 transcriptionally regulates Bcl-2 through a WT1-binding site on the bcl-2 promoter. J Biol Chem 278: 19995-20005.
-
(2003)
J Biol Chem
, vol.278
, pp. 19995-20005
-
-
Cheema, S.K.1
Mishra, S.K.2
Rangnekar, V.M.3
Tari, A.M.4
Kumar, R.5
Lopez-Berestein, G.6
-
7
-
-
3042681854
-
17beta-estradiol-induced activation of ERK1/2 through endogenous androgen receptor-estradiol receptor alpha-Src complex in human prostate cells
-
Chieffi P, Kisslinger A, Sinisi AA, Abbondanza C, Tramontano D. 2003. 17beta-estradiol-induced activation of ERK1/2 through endogenous androgen receptor-estradiol receptor alpha-Src complex in human prostate cells. Int J Oncol 23: 797-801.
-
(2003)
Int J Oncol
, vol.23
, pp. 797-801
-
-
Chieffi, P.1
Kisslinger, A.2
Sinisi, A.A.3
Abbondanza, C.4
Tramontano, D.5
-
8
-
-
33746623315
-
Molecular regulation of androgen action in prostate cancer
-
Dehm SM, Tindall DJ. 2006. Molecular regulation of androgen action in prostate cancer. J Cell Biochem 99: 33-44.
-
(2006)
J Cell Biochem
, vol.99
, pp. 33-44
-
-
Dehm, S.M.1
Tindall, D.J.2
-
9
-
-
33751243012
-
Selective estrogen receptor modulators (SERMS)
-
Diez-Perez A. 2006. Selective estrogen receptor modulators (SERMS). Arq Bras Endocrinol Metabol 50: 720-734.
-
(2006)
Arq Bras Endocrinol Metabol
, vol.50
, pp. 720-734
-
-
Diez-Perez, A.1
-
10
-
-
0033775525
-
Molecular mechanisms of selective estrogen receptor modulator (SERM) action
-
Dutertre M, Smith CL. 2000. Molecular mechanisms of selective estrogen receptor modulator (SERM) action. J Pharmacol Exp Ther 295: 431-437.
-
(2000)
J Pharmacol Exp Ther
, vol.295
, pp. 431-437
-
-
Dutertre, M.1
Smith, C.L.2
-
11
-
-
61749095503
-
The dual, opposing roles of estrogen in the prostate
-
Ellem SJ, Risbridger GP. 2009. The dual, opposing roles of estrogen in the prostate. Ann NY Acad Sci 1155: 174-186.
-
(2009)
Ann NY Acad Sci
, vol.1155
, pp. 174-186
-
-
Ellem, S.J.1
Risbridger, G.P.2
-
12
-
-
33847638137
-
Estimates of the cancer incidence and mortality in Europe in 2006
-
Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. 2007. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18: 581-592.
-
(2007)
Ann Oncol
, vol.18
, pp. 581-592
-
-
Ferlay, J.1
Autier, P.2
Boniol, M.3
Heanue, M.4
Colombet, M.5
Boyle, P.6
-
13
-
-
29244452627
-
Modulation of RIZ gene expression is associated to estradiol control of MCF-7 breast cancer cell proliferation
-
Gazzerro P, Abbondanza C, D'Arcangelo A, Rossi M, Medici N, Moncharmont B, Puca GA. 2006. Modulation of RIZ gene expression is associated to estradiol control of MCF-7 breast cancer cell proliferation. Exp Cell Res 312: 340-349.
-
(2006)
Exp Cell Res
, vol.312
, pp. 340-349
-
-
Gazzerro, P.1
Abbondanza, C.2
D'Arcangelo, A.3
Rossi, M.4
Medici, N.5
Moncharmont, B.6
Puca, G.A.7
-
14
-
-
0035816730
-
Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to PAR2 and PAR4 agonists
-
Hamilton JR, Frauman AG, Cocks TM. 2001. Increased expression of protease-activated receptor-2 (PAR2) and PAR4 in human coronary artery by inflammatory stimuli unveils endothelium-dependent relaxations to PAR2 and PAR4 agonists. Circ Res 89: 92-98.
-
(2001)
Circ Res
, vol.89
, pp. 92-98
-
-
Hamilton, J.R.1
Frauman, A.G.2
Cocks, T.M.3
-
15
-
-
0035106357
-
Regulation of methallothionein HH messenger ribonucleic and measures exogenous estrogen receptor-β activity in SAOS-2 and LNCaPLN3 cells
-
Harris HA, Henderson RA, Bhat RA, Komm BS. 2001. Regulation of methallothionein HH messenger ribonucleic and measures exogenous estrogen receptor-β activity in SAOS-2 and LNCaPLN3 cells. Endocrinology 142: 645-652.
-
(2001)
Endocrinology
, vol.142
, pp. 645-652
-
-
Harris, H.A.1
Henderson, R.A.2
Bhat, R.A.3
Komm, B.S.4
-
16
-
-
2342558431
-
Androgen receptor in prostate cancer
-
Heinlein CA, Chang C. 2004. Androgen receptor in prostate cancer. Endocr Rev 25: 276-308.
-
(2004)
Endocr Rev
, vol.25
, pp. 276-308
-
-
Heinlein, C.A.1
Chang, C.2
-
17
-
-
3843145374
-
Estrogens and anti-estrogens: Key mediators of prostate carcinogenesis and new therapeutic candidates
-
Ho SM. 2004. Estrogens and anti-estrogens: Key mediators of prostate carcinogenesis and new therapeutic candidates. J Cell Biochem 91: 491-503.
-
(2004)
J Cell Biochem
, vol.91
, pp. 491-503
-
-
Ho, S.M.1
-
18
-
-
0035878926
-
Frequent loss of estrogen receptor-beta expression in prostate cancer
-
Horvath LG, Henshall SM, Lee CS, Head DR, Quinn DI, Makela S, Delprado W, Golovsky D, Brenner PC, O'Neill G, Kooner R, Stricker PD, Grygiel JJ, Gustafsson JA, Sutherland RL. 2001. Frequent loss of estrogen receptor-beta expression in prostate cancer. Cancer Res 61: 5331-5335.
-
(2001)
Cancer Res
, vol.61
, pp. 5331-5335
-
-
Horvath, L.G.1
Henshall, S.M.2
Lee, C.S.3
Head, D.R.4
Quinn, D.I.5
Makela, S.6
Delprado, W.7
Golovsky, D.8
Brenner, P.C.9
O'Neill, G.10
Kooner, R.11
Stricker, P.D.12
Grygiel, J.J.13
Gustafsson, J.A.14
Sutherland, R.L.15
-
19
-
-
0036581024
-
Prostate phenotypes in estrogen-modulated transgenic mice
-
Jarred RA, McPherson SJ, Bianco JJ, Couse JF, Korach KS, Risbridger GP. 2002. Prostate phenotypes in estrogen-modulated transgenic mice. Trends Endocrinol Metab 13: 163-168.
-
(2002)
Trends Endocrinol Metab
, vol.13
, pp. 163-168
-
-
Jarred, R.A.1
McPherson, S.J.2
Bianco, J.J.3
Couse, J.F.4
Korach, K.S.5
Risbridger, G.P.6
-
20
-
-
1542348477
-
American Cancer Society 2004. Cancer statistics
-
Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ. 2004. American Cancer Society 2004. Cancer statistics. CA Cancer J Clin 54: 8-29.
-
(2004)
CA Cancer J Clin
, vol.54
, pp. 8-29
-
-
Jemal, A.1
Tiwari, R.C.2
Murray, T.3
Ghafoor, A.4
Samuels, A.5
Ward, E.6
Feuer, E.J.7
Thun, M.J.8
-
21
-
-
0037105670
-
Raloxifene a mixed estrogen agonist/antagonist, induces apoptosis inandrogen-independent human prostate cancer cell lines
-
Kim IY, Kim BC, Seong DH, Lee DK, Seo JM, Hong YJ, Kim HT, Morton RA, Kim SJ. 2002a. Raloxifene a mixed estrogen agonist/antagonist, induces apoptosis inandrogen-independent human prostate cancer cell lines. Cancer Res 62: 5365-5369.
-
(2002)
Cancer Res
, vol.62
, pp. 5365-5369
-
-
Kim, I.Y.1
Kim, B.C.2
Seong, D.H.3
Lee, D.K.4
Seo, J.M.5
Hong, Y.J.6
Kim, H.T.7
Morton, R.A.8
Kim, S.J.9
-
22
-
-
0036645127
-
Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway
-
Kim IY, Seong DH, Kim BC, Lee DK, Remaley AT, Leach F, Morton RA, Kim SJ. 2002b. Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway. Cancer Res 62: 3649-3653.
-
(2002)
Cancer Res
, vol.62
, pp. 3649-3653
-
-
Kim, I.Y.1
Seong, D.H.2
Kim, B.C.3
Lee, D.K.4
Remaley, A.T.5
Leach, F.6
Morton, R.A.7
Kim, S.J.8
-
23
-
-
0037031813
-
Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis through cleavage of BAD in TSU-PR1 human cancer cells
-
Kim HT, Kim BC, Kim IY, Mamura M, Seong DH, Jang JJ, Kim SJ. 2002c. Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis through cleavage of BAD in TSU-PR1 human cancer cells. J Biol Chem 277: 32510-32515.
-
(2002)
J Biol Chem
, vol.277
, pp. 32510-32515
-
-
Kim, H.T.1
Kim, B.C.2
Kim, I.Y.3
Mamura, M.4
Seong, D.H.5
Jang, J.J.6
Kim, S.J.7
-
24
-
-
18844429222
-
Reflections on the discovery and significance of estrogen receptor beta
-
Koehler KF, Helguero LA, Haldosen LA, Warner M, Gustafsson JA. 2005. Reflections on the discovery and significance of estrogen receptor beta. Endocr Rev 26: 465-478.
-
(2005)
Endocr Rev
, vol.26
, pp. 465-478
-
-
Koehler, K.F.1
Helguero, L.A.2
Haldosen, L.A.3
Warner, M.4
Gustafsson, J.A.5
-
25
-
-
0035266404
-
Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays
-
Latil A, Bièche I, Vidaud D, Lidereau R, Berthon P, Cussenot O, Vidaud M. 2001. Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays. Cancer Res 61: 1919-1926.
-
(2001)
Cancer Res
, vol.61
, pp. 1919-1926
-
-
Latil, A.1
Bièche, I.2
Vidaud, D.3
Lidereau, R.4
Berthon, P.5
Cussenot, O.6
Vidaud, M.7
-
26
-
-
0034126666
-
Expression of estrogen receptor (ER)-α and ER-ß in normal and malignant prostatic epithelial cells: Regulation by methylation and involvement in growth regulation
-
Lau K-M, LaSpina M, Long J, Ho S-M. 2000. Expression of estrogen receptor (ER)-α and ER-ß in normal and malignant prostatic epithelial cells: Regulation by methylation and involvement in growth regulation. Cancer Res 60: 3175-3182.
-
(2000)
Cancer Res
, vol.60
, pp. 3175-3182
-
-
Lau, K.-M.1
LaSpina, M.2
Long, J.3
Ho, S.-M.4
-
27
-
-
0035408472
-
Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma
-
Leav I, Lau KM, Adams JY, McNeal JE, Taplin ME, Wang J, Singh H, Ho SM. 2001. Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. Am J Pathol 159: 79-92.
-
(2001)
Am J Pathol
, vol.159
, pp. 79-92
-
-
Leav, I.1
Lau, K.M.2
Adams, J.Y.3
McNeal, J.E.4
Taplin, M.E.5
Wang, J.6
Singh, H.7
Ho, S.M.8
-
28
-
-
57049144758
-
Prostate cancer 2008:challenges in diagnosis and management
-
Marberger M. 2009. Prostate cancer 2008:challenges in diagnosis and management. Eur Urol 3: 89-96.
-
(2009)
Eur Urol
, vol.3
, pp. 89-96
-
-
Marberger, M.1
-
29
-
-
33846413629
-
Essential role for estrogen receptor beta in stromal-epithelial regulation of prostatic hyperplasia
-
McPherson SJ, Ellem SJ, Simpson ER, Patchev V, Fritzemeier KH, Risbridger GP. 2007. Essential role for estrogen receptor beta in stromal-epithelial regulation of prostatic hyperplasia. Endocrinology 148: 566-574.
-
(2007)
Endocrinology
, vol.148
, pp. 566-574
-
-
McPherson, S.J.1
Ellem, S.J.2
Simpson, E.R.3
Patchev, V.4
Fritzemeier, K.H.5
Risbridger, G.P.6
-
30
-
-
0033517825
-
Identification of a DNA binding protein cooperating with estrogen receptor as RIZ (retinoblastoma interacting zinc finger protein)
-
Medici N, Abbondanza C, Nigro V, Rossi V, Piluso G, Belsito A, et al. 1999. Identification of a DNA binding protein cooperating with estrogen receptor as RIZ (retinoblastoma interacting zinc finger protein). Biochem Biophys Res Commun 264: 983-989.
-
(1999)
Biochem Biophys Res Commun
, vol.264
, pp. 983-989
-
-
Medici, N.1
Abbondanza, C.2
Nigro, V.3
Rossi, V.4
Piluso, G.5
Belsito, A.6
-
31
-
-
0035884610
-
Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP)
-
Mentor-Marcel R, Lamartiniere CA, Eltoum IE, Greenberg NM, Elgavish A. 2001. Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP). Cancer Res 61: 6777-6782.
-
(2001)
Cancer Res
, vol.61
, pp. 6777-6782
-
-
Mentor-Marcel, R.1
Lamartiniere, C.A.2
Eltoum, I.E.3
Greenberg, N.M.4
Elgavish, A.5
-
32
-
-
0034675994
-
Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation
-
Migliaccio A, Castoria G, Di Domenico M, de Falco A, Bilancio A, Lombardi M, Barone MV, Ametrano D, Zannini MS, Abbondanza C, Auricchio F. 2000. Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. EMBO J 19: 5406-5417.
-
(2000)
EMBO J
, vol.19
, pp. 5406-5417
-
-
Migliaccio, A.1
Castoria, G.2
Di Domenico, M.3
de Falco, A.4
Bilancio, A.5
Lombardi, M.6
Barone, M.V.7
Ametrano, D.8
Zannini, M.S.9
Abbondanza, C.10
Auricchio, F.11
-
33
-
-
0038318941
-
Sex steroid hormones act as growth factors
-
Migliaccio A, Castoria G, Di Domenico M, de Falco A, Bilancio A, Lombardi M, Bottero D, Varricchio L, Nanayakkara M, Rotondi A, Auricchio F. 2002. Sex steroid hormones act as growth factors. J Steroid Biochem Mol Biol 83: 31-35.
-
(2002)
J Steroid Biochem Mol Biol
, vol.83
, pp. 31-35
-
-
Migliaccio, A.1
Castoria, G.2
Di Domenico, M.3
de Falco, A.4
Bilancio, A.5
Lombardi, M.6
Bottero, D.7
Varricchio, L.8
Nanayakkara, M.9
Rotondi, A.10
Auricchio, F.11
-
34
-
-
34648849274
-
Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth
-
Migliaccio A, Varricchio L, De Falco A, Castoria G, Arra C, Yamaguchi H, Ciociola A, Lombardi M, Di Stasio R, Barbieri A, Baldi A, Barone MV, Appella E, Auricchio F. 2007. Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth. Oncogene 26: 6619-6629.
-
(2007)
Oncogene
, vol.26
, pp. 6619-6629
-
-
Migliaccio, A.1
Varricchio, L.2
De Falco, A.3
Castoria, G.4
Arra, C.5
Yamaguchi, H.6
Ciociola, A.7
Lombardi, M.8
Di Stasio, R.9
Barbieri, A.10
Baldi, A.11
Barone, M.V.12
Appella, E.13
Auricchio, F.14
-
35
-
-
0038081046
-
Retinoic acid inhibits the growth of bone marrow mesenchymal stem cells and induces p27Kip1 and p16INK4A up-regulation
-
Oliva A, Borriello A, Zeppetelli S, Di Feo A, Cortellazzi P, Ventriglia V, Criscuolo M, Zappia V, Della Ragione F. 2003. Retinoic acid inhibits the growth of bone marrow mesenchymal stem cells and induces p27Kip1 and p16INK4A up-regulation. Mol Cell Biochem 247: 55-60.
-
(2003)
Mol Cell Biochem
, vol.247
, pp. 55-60
-
-
Oliva, A.1
Borriello, A.2
Zeppetelli, S.3
Di Feo, A.4
Cortellazzi, P.5
Ventriglia, V.6
Criscuolo, M.7
Zappia, V.8
Della Ragione, F.9
-
36
-
-
0034999987
-
Loss of estrogen receptor beta expression in malignant human prostate cells in primary cultures and in prostate cancer tissues
-
Pasquali D, Rossi V, Esposito D, Abbondanza C, Puca GA, Bellastella A, Sinisi AA. 2001a. Loss of estrogen receptor beta expression in malignant human prostate cells in primary cultures and in prostate cancer tissues. J Clin Endocrinol Metab 86: 2051-2055.
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 2051-2055
-
-
Pasquali, D.1
Rossi, V.2
Esposito, D.3
Abbondanza, C.4
Puca, G.A.5
Bellastella, A.6
Sinisi, A.A.7
-
37
-
-
0035912874
-
Estrogen receptor beta expression in human prostate tissue
-
Pasquali D, Staibano S, Prezioso D, Franco R, Esposito D, Notaro A, De Rosa G, Bellastella A, Sinisi AA. 2001b. Estrogen receptor beta expression in human prostate tissue. Mol Cell Endocrinol 178: 47-50.
-
(2001)
Mol Cell Endocrinol
, vol.178
, pp. 47-50
-
-
Pasquali, D.1
Staibano, S.2
Prezioso, D.3
Franco, R.4
Esposito, D.5
Notaro, A.6
De Rosa, G.7
Bellastella, A.8
Sinisi, A.A.9
-
38
-
-
0033621962
-
17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence
-
Perillo B, Sasso A, Abbondanza C, Palumbo G. 2000. 17beta-estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol Cell Biol 20: 2890-2901.
-
(2000)
Mol Cell Biol
, vol.20
, pp. 2890-2901
-
-
Perillo, B.1
Sasso, A.2
Abbondanza, C.3
Palumbo, G.4
-
39
-
-
38149045693
-
DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression
-
Perillo B, Ombra MN, Bertoni A, Cuozzo C, Sacchetti S, Sasso A, Chiariotti L, Malorni A, Abbondanza C, Avvedimento EV. 2008. DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression. Science 319: 202-206.
-
(2008)
Science
, vol.319
, pp. 202-206
-
-
Perillo, B.1
Ombra, M.N.2
Bertoni, A.3
Cuozzo, C.4
Sacchetti, S.5
Sasso, A.6
Chiariotti, L.7
Malorni, A.8
Abbondanza, C.9
Avvedimento, E.V.10
-
40
-
-
0344142396
-
Emerging roles of caspase-3-3 in apoptosis
-
Porter AG, Jänicke RU. 1999. Emerging roles of caspase-3-3 in apoptosis. Cell Death Differ 6: 99-104.
-
(1999)
Cell Death Differ
, vol.6
, pp. 99-104
-
-
Porter, A.G.1
Jänicke, R.U.2
-
41
-
-
0008881181
-
Mutually exclusive expression patterns of Bcl-2 and PAR-4 in human prostate tumors consistent with down-regulation of Bcl-2 by PAR-4
-
Qiu G, Ahmed M, Sells SF, Mohiuddin M, Weinstein MH, Rangnekar VM. 1999. Mutually exclusive expression patterns of Bcl-2 and PAR-4 in human prostate tumors consistent with down-regulation of Bcl-2 by PAR-4. Oncogene 18: 623-631.
-
(1999)
Oncogene
, vol.18
, pp. 623-631
-
-
Qiu, G.1
Ahmed, M.2
Sells, S.F.3
Mohiuddin, M.4
Weinstein, M.H.5
Rangnekar, V.M.6
-
42
-
-
70449715269
-
Expression of RIZ1 protein (Retinoblastoma-interacting zinc-finger protein 1) in prostate cancer epithelial cells changes with cancer grade progression and is modulated in vitro by DHT and E2
-
Rossi V, Staibano S, Abbondanza C, Pasquali D, De Rosa C, Mascolo M, Bellastella G, Visconti D, De Bellis A, Moncharmont B, De Rosa G, Puca GA, Bellastella A, Sinisi AA. 2009. Expression of RIZ1 protein (Retinoblastoma-interacting zinc-finger protein 1) in prostate cancer epithelial cells changes with cancer grade progression and is modulated in vitro by DHT and E2. J Cell Physiol 221: 771-777.
-
(2009)
J Cell Physiol
, vol.221
, pp. 771-777
-
-
Rossi, V.1
Staibano, S.2
Abbondanza, C.3
Pasquali, D.4
De Rosa, C.5
Mascolo, M.6
Bellastella, G.7
Visconti, D.8
De Bellis, A.9
Moncharmont, B.10
De Rosa, G.11
Puca, G.A.12
Bellastella, A.13
Sinisi, A.A.14
-
43
-
-
33644895429
-
Raloxifene, an oestrogen-receptor-beta-targeted therapy, inhibits androgen-independent prostate cancer growth: Results from preclinical studies and a pilot phase II clinical trial
-
Shazer RL, Jain A, Galkin AV, Cinman N, Nguyen KN, Natale RB, Gross M, Green L, Bender LI, Holden S, Kaplan L, Agus DB. 2006. Raloxifene, an oestrogen-receptor-beta-targeted therapy, inhibits androgen-independent prostate cancer growth: Results from preclinical studies and a pilot phase II clinical trial. BJU Int 97: 691-697.
-
(2006)
BJU Int
, vol.97
, pp. 691-697
-
-
Shazer, R.L.1
Jain, A.2
Galkin, A.V.3
Cinman, N.4
Nguyen, K.N.5
Natale, R.B.6
Gross, M.7
Green, L.8
Bender, L.I.9
Holden, S.10
Kaplan, L.11
Agus, D.B.12
-
44
-
-
0036249557
-
EPN: A novel epithelial cell line derived from human prostate tissue
-
Sinisi AA, Chieffi P, Pasquali D, Kisslinger A, Staibano S, Bellastella A, Tramontano D. 2002. EPN: A novel epithelial cell line derived from human prostate tissue. In Vitro Cell Dev Biol Anim 38: 165-172.
-
(2002)
In Vitro Cell Dev Biol Anim
, vol.38
, pp. 165-172
-
-
Sinisi, A.A.1
Chieffi, P.2
Pasquali, D.3
Kisslinger, A.4
Staibano, S.5
Bellastella, A.6
Tramontano, D.7
-
45
-
-
34547375041
-
Selective estrogen receptor modulators to prevent treatment-related osteoporosis
-
Smith MR. 2005. Selective estrogen receptor modulators to prevent treatment-related osteoporosis. Rev Urol 7: S30-S35.
-
(2005)
Rev Urol
, vol.7
-
-
Smith, M.R.1
-
46
-
-
33750688843
-
Treatment-related osteoporosis in men with prostate cancer
-
Smith MR. 2006. Treatment-related osteoporosis in men with prostate cancer. Clin Cancer Res 12: 6315s-6319s.
-
(2006)
Clin Cancer Res
, vol.12
-
-
Smith, M.R.1
-
49
-
-
22344444907
-
Inhibition of prostate carcinogenesis in probasin/SV40 T antigen transgenic rats by raloxifene, an antiestrogen with anti-androgen action, but not nimesulide, a selective cyclooxygenase-2 inhibitor
-
Zeng Y, Yokohira M, Saoo K, Takeuchi H, Chen Y, Yamakawa K, Matsuda Y, Kakehi Y, Imaida K. 2005. Inhibition of prostate carcinogenesis in probasin/SV40 T antigen transgenic rats by raloxifene, an antiestrogen with anti-androgen action, but not nimesulide, a selective cyclooxygenase-2 inhibitor. Carcinogenesis 26: 1109-1116.
-
(2005)
Carcinogenesis
, vol.26
, pp. 1109-1116
-
-
Zeng, Y.1
Yokohira, M.2
Saoo, K.3
Takeuchi, H.4
Chen, Y.5
Yamakawa, K.6
Matsuda, Y.7
Kakehi, Y.8
Imaida, K.9
-
50
-
-
58149116505
-
Apoptosis and tumor resistance conferred by PAR-4
-
Zhao Y, Rangnekar VM. 2008. Apoptosis and tumor resistance conferred by PAR-4. Cancer Biol Ther 7: 1867-1874.
-
(2008)
Cancer Biol Ther
, vol.7
, pp. 1867-1874
-
-
Zhao, Y.1
Rangnekar, V.M.2
|